Research guide · Published July 22, 2026 · Sources checked July 22, 2026

How to read a peptide COA: HPLC, mass spectrometry, and identity

A Certificate of Analysis is useful only when its methods, sample, results, and batch linkage are clear. One purity percentage cannot answer every identity and quality question.

Short answer

HPLC commonly estimates chromatographic purity under a defined separation method; mass spectrometry tests molecular mass and can help characterize identity or impurities. Neither result alone establishes peptide content, sequence, sterility, endotoxin status, or suitability for a particular experiment.

Evidence boundary: This guide explains analytical concepts. It does not certify any batch, replace laboratory method validation, or establish suitability for human or animal use. Catalog materials are supplied only for qualified in vitro laboratory research and are not for human or animal use.

Comparison at a glance

COA elementQuestion it can addressWhat it cannot establish alone
Batch or lot identifierWhether the report is linked to a specific supplied batchWhether the test itself was technically adequate
HPLC chromatogramRelative chromatographic peak area under stated conditionsComplete molecular identity or absolute peptide content
Mass spectrumObserved molecular mass and selected identity informationSeparation of every isomer or accurate total purity by itself
Reference standard and methodHow the result was assigned and comparedTransferability to a different method or instrument without validation
Signature and test dateDocument accountability and timingUnreported storage history or future stability

How to interpret the comparison

Orthogonal methods reduce blind spots because chromatography and mass spectrometry answer different analytical questions. A single retention time is generally less specific than a combination of techniques.

A chromatographic area percentage is not necessarily the mass fraction of active peptide in a vial. Water, counterions, residual solvents, and structurally related impurities may require additional measurements.

Primary sources

  1. Li et al., Analytical and Bioanalytical Chemistry (2018) — LC–high-resolution-MS identification and quantification of structurally related impurities in synthetic human C-peptide. DOI: 10.1007/s00216-018-1155-y
  2. McCarthy et al., Pharmaceutical Research (2023) — Reference-standard case studies using NMR, mass spectrometry, chromatography, and mass-balance approaches. DOI: 10.1007/s11095-023-03493-1
  3. Petersson et al., Journal of Chromatography A (2023) — Two-dimensional LC–MS strategy showing why co-eluting peptide isomers can complicate main-peak purity assessment. DOI: 10.1016/j.chroma.2023.463874

Continue in the research library

Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.